ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Hematology Oncology

Top Hematology Oncology Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SUMATI GUPTA MD

Hematology Oncology

3,066

$214K

142
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

14%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 13%

$70
Average prescription price

Avg: $329

CARL GRAY M.D.

Hematology Oncology

2,011

$618K

217
189 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

22%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 13%

$307
Average prescription price

Avg: $329

HAROLD JOHNSON M.D.

Hematology Oncology

1,362

$264K

152
129 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 13%

$194
Average prescription price

Avg: $329

JOSEPH TE M.D.

Hematology Oncology

1,347

$541K

254
220 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 13%

$402
Average prescription price

Avg: $329

DERRICK HASLEM MD

Hematology Oncology

1,311

$216K

208
180 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 13%

$165
Average prescription price

Avg: $329

ANNA BECK M.D.

Hematology Oncology

1,163

$265K

174
150 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

14%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 13%

$228
Average prescription price

Avg: $329

VINCENT HANSEN MD

Hematology Oncology

1,119

$326K

176
151 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

19%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 13%

$292
Average prescription price

Avg: $329

ALI BEN-JACOB MD

Hematology Oncology

1,004

$450K

142
128 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

18%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 13%

$448
Average prescription price

Avg: $329

JUSTIN CALL M.D.

Hematology Oncology

925

$283K

195
156 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 13%

$306
Average prescription price

Avg: $329

WENDY BREYER MD

Hematology Oncology

908

$446K

131
111 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 13%

$491
Average prescription price

Avg: $329

JAY BOTT MD

Hematology Oncology

847

$517K

131
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 13%

$611
Average prescription price

Avg: $329

KARIM ANWAR M.D.

Hematology Oncology

820

$247K

175
158 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 13%

$302
Average prescription price

Avg: $329

SCOTT SAMUELSON M.D.

Hematology Oncology

794

$202K

129
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 13%

$254
Average prescription price

Avg: $329

GREGORY LITTON M.D.

Hematology Oncology

782

$101K

145
133 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 13%

$129
Average prescription price

Avg: $329

BRIAN TUDOR MD

Hematology Oncology

781

$418K

118
105 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 9%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 13%

$535
Average prescription price

Avg: $329

STEVEN WALLENTINE MD

Hematology Oncology

749

$466K

134
113 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 13%

$623
Average prescription price

Avg: $329

NITIN CHANDRAMOULI MD

Hematology Oncology

729

$362K

128
112 are 65+

21%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 13%

$497
Average prescription price

Avg: $329

WILLIAM NIBLEY M.D.

Hematology Oncology

680

$263K

131
116 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 13%

$387
Average prescription price

Avg: $329

JASON STINNETT MD

Hematology Oncology

601

$350K

98
83 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 13%

$583
Average prescription price

Avg: $329

RICHARD FRAME MD

Hematology Oncology

591

$227K

127
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

22%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 13%

$383
Average prescription price

Avg: $329

REGINA KLEIN

Hematology Oncology

568

$57.2K

105
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 13%

$101
Average prescription price

Avg: $329

GREGORY CHIPMAN M.D.

Hematology Oncology

559

$551K

79
65 are 65+

33%
patients receiving schedule two controlled substances

Avg: 10%

19%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 13%

$985
Average prescription price

Avg: $329

WILLIAM HARKER M.D.

Hematology Oncology

552

$177K

134
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 13%

$321
Average prescription price

Avg: $329

JONATHAN WHISENANT M.D.

Hematology Oncology

543

$410K

132
113 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 13%

$755
Average prescription price

Avg: $329

NATHAN RICH M.D.

Hematology Oncology

499

$198K

97
79 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 13%

$396
Average prescription price

Avg: $329

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank